Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard(Université Paris-Sud), Anaïs Dupré(Institut Curie), Marina Bermisheva(Russian Academy of Sciences), Volker Arndt(German Cancer Research Center), Michael Lush(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Jonathan P. Tyrer(University of Cambridge), Banu Arun(The University of Texas Health Science Center at Houston), Wendy K. Chung(Oregon Health & Science University), Jose E. Castelao(Servicio Gallego de Salud), Jenny Chang‐Claude(Universität Hamburg), Goska Leslie(University of Cambridge), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Kathleen Claes(Statistics Belgium), Joe Dennis(University of Cambridge), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Caroline Baynes(University of Cambridge), Sandrine M. Caputo(Institut Curie), Daniel Barrowdale(University of Cambridge), Thomas U. Ahearn(Harvard University), Leslie Bernstein(National Cancer Institute), Irene L. Andrulis(University of Toronto), Katarzyna Białkowska(International Hereditary Cancer Center), Daniel R. Barnes(University of Cambridge), Christine L. Clarke(Memorial University of Newfoundland), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Carl Blomqvist(University of Helsinki), Brian D. Carter(American Cancer Society), Daniele Campa(University of Pisa), Stig E. Bojesen(University of Copenhagen), Saundra S. Buys(University of Utah), Tracy A. O’Mara(QIMR Berghofer Medical Research Institute), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Muriel A. Adank(The Netherlands Cancer Institute), Ophélie Bertrand(Institut Curie), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Simona Agata(Roswell Park Comprehensive Cancer Center), Barbara Burwinkel(German Cancer Research Center), Kristiina Aittomäki(University of Helsinki), Lesley McGuffog(University of Cambridge), Åke Borg(Lund University), Heko Becher(Universität Hamburg), Manjeet K. Bolla(University of Cambridge), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Annelie Augustinsson(Lund University)
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k